VENUS: Septic Gene Expression Using SeptiCyte

CompletedOBSERVATIONAL
Enrollment

379

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

December 31, 2016

Conditions
SepsisSystemic Inflammatory Response Syndrome (SIRS)
Trial Locations (6)

11040

Northwell Health, New Hyde Park

21205

Johns Hopkins Hospital, Baltimore

30303

Grady Memorial Hospital, Atlanta

60153

Loyola University Medical Center, Maywood

60612

Rush University Medical Center, Chicago

84157-7000

Intermountain Medical Center, Murray

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Intermountain Health Care, Inc.

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

Rush University Medical Center

OTHER

collaborator

Northwell Health

OTHER

collaborator

Loyola University

OTHER

collaborator

Grady Memorial Hospital

OTHER

lead

Immunexpress

INDUSTRY

NCT02127502 - VENUS: Septic Gene Expression Using SeptiCyte | Biotech Hunter | Biotech Hunter